Guideline for the diagnosis and management of myelofibrosis
Open Access
- 1 June 2012
- journal article
- guideline
- Published by Wiley in British Journal of Haematology
- Vol. 158 (4) , 453-471
Abstract
Summary: The guideline group regarding the diagnosis and management of myelofibrosis was selected to be representative of UK‐based medical experts, together with a contribution from a single expert from the USA. MEDLINE and EMBASE were searched systematically for publications in English from 1966 until August 2011 using a variety of key words. The writing group produced the draft guideline, which was subsequently revised by consensus of the members of the General Haematology and Haemato‐oncology Task Forces of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. The criteria used to state levels and grades of evidence are as outlined in the Procedure for Guidelines commissioned by the BCSH; the ‘GRADE‘ system was used to score strength and quality of evidence. The objective of this guideline is to provide healthcare professionals with clear guidance on the investigation and management of primary myelofibrosis, as well as post‐polycythaemic myelofibrosis (post‐PV MF) and post‐thrombocythemic myelofibrosis (post‐ET MF) in both adult and paediatric patients.Keywords
This publication has 115 references indexed in Scilit:
- The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationBlood, 2012
- Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesBlood, 2011
- Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of ageBritish Journal of Haematology, 2011
- How I treat essential thrombocythemiaBlood, 2011
- Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSSHaematologica, 2010
- Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenaseHaematologica, 2010
- Outcome of Transplantation for MyelofibrosisTransplantation and Cellular Therapy, 2010
- Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor typeBone Marrow Transplantation, 2009
- Allogeneic hematopoietic cell transplantation for patients with myelofibrosisCurrent Opinion in Hematology, 2009
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006